Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

NACompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions
Alzheimer's Disease
Interventions
DEVICE

TMS and cognitive stimulation

Synchronized TMS and cognitive stimulation to 6 brain areas.

DEVICE

sham

Trial Locations (10)

10016

NYU Langone Medical Center, New York

33137

Miami Jewish Health Systems, Miami

33407

Palm Beach Neurology and Premiere Research Institute, West Palm Beach

34243

Roskamp Institute Clinic, Sarasota

44107

Cleveland Clinic Center for Brain Health Lakewood Hospital, Cleveland

85351

Banner Sun Health Research Institute, Sun City

89106

Cleveland Clinic Lou Ruvo Brain Center, Las Vegas

92626

ATP Clinical Research, Inc., Costa Mesa

02215

Beth Israel Deaconess Medical Center, Boston

Unknown

Assaf Harofe Medical Center, Beer Yaakov

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Neuronix Ltd

INDUSTRY

NCT01825330 - Effect of NeuroAD on the Cognitive Function of Alzheimer Patients | Biotech Hunter | Biotech Hunter